Abstract Raver1, a ubiquitously expressed protein, was originally identified as a ligand for metavinculin, the muscle-specific isoform of the microfilament-associated protein vinculin. The protein resides primarily in the nucleus, where it colocalises and may interact with polypyrimidine-tract-binding protein, which is involved in alternative splicing processes. During skeletal muscle differentiation, raver1 translocates to the cytoplasm and eventually targets the Z-line of sarcomeres. Here, it colocalises with metavinculin, vinculin and alpha-actinin, all of which have biochemically been identified as raver1 ligands. To obtain more information about the potential role of raver1 in muscle structure and function, we have investigated its distribution and fine localisation in mouse striated and smooth muscle, by using three monoclonal antibodies that recognise epitopes in different regions of the raver1 protein. Our immunofluorescence and immunoelectron-microscopic results indicate that the cytoplasmic accumulation of raver1 is not confined to skeletal muscle but also occurs in heart and smooth muscle. Unlike vinculin and metavinculin, cytoplasmic raver1 is not restricted to costameres but additionally represents an integral part of the sarcomere. In isolated myofibrils and in ultrathin sections of skeletal muscle, raver1 has been found concentrated at the I-Z-I band. A minor fraction of raver1 is present in the nuclei of all three types of muscle. These data indicate that, during muscle differentiation, raver1 might link gene expression with structural functions of the contractile machinery of muscle.
Introduction
Muscle contraction critically depends on the precise interplay of myofibrils anchored to and associated with structural and regulatory proteins. This is best demonstrated for striated muscle in which the contractile apparatus is organised into regular repeating units (the sarcomeres) whose integrity is essential for proper muscle function. Metabolic labelling and transfection studies have shown that fully differentiated muscle, in spite of its rigid appearance, is a highly dynamic structure with a constant turnover of individual components, albeit at different rates (Zak et al. 1977; Martin 1981; Michele et al. 1999; Littlefield et al. 2001) . Even proteins previously perceived as static components of the Z-disc, such as alpha-actinin or myotilin, are in a continuous exchange with a cytoplasmic pool (Wang et al. 2005) . Furthermore, muscle is able to respond to changes in mechanical strain by altering the equilibrium between protein synthesis and degradation (Janmey 1998; Ruwhof and van der Laarse 2000; Russell et al. 2000) . However, the way in which the turnover of individual components is achieved while muscle function is maintained is still poorly understood.
Some of the muscle proteins exhibit a dual residency: at the sarcomere and in the nucleus. These proteins have been suggested to function as messengers that link gene expression to myofibril signalling pathways. Indeed, there is increasing evidence that sarcomeric constituents appear at different subcellular locations in response to different stimuli, both within the sarcomere and in other cellular compartments, such as the nucleus (for reviews, see Clark et al. 2002; Lange et al. 2006) . These findings imply that the sarcomere not only provides the structural basis for muscle contraction, but also serves as a communicative platform where signals are both perceived and transmitted, thereby allowing for the functional plasticity of muscle tissue.
A candidate messenger protein in muscle differentiation or maintenance is raver1 (Fig. 1a) , a ubiquitously expressed 80-kDa protein that contains three RNA-recognition motifs (RRMs) with a high sequence homology to members of the heterogeneous ribonucleoprotein (hnRNP) family (Huttelmaier et al. 2001; . In most cell types, raver1 is found in the nucleus but displays nucleocytoplasmic shuttling, presumably mediated by two nuclear localisation signals at the N-and C-termini and a putative export sequence located within the central leucinerich region. In the nucleus, raver1 may associate with another hnRNP, the polypyrimidine-tract-binding protein (PTB), a potent regulator of the alternative splicing of several genes (Valcarcel and Gebauer 1997) . Direct binding of raver1 to PTB has been demonstrated in vitro and both proteins colocalise in the perinucleolar compartment, an RNAdependent structure that is characterised by the accumulation of PTB (Ghetti et al. 1992) . Furthermore, raver1-PTB complexes can be immunoprecipitated from vertebrate cells (Huttelmaier et al. 2001) . Whereas direct RNA binding of raver1 has yet to be demonstrated, the protein may assist in PTB-mediated splicing events in smooth muscle (Gromak et al. 2003; Spellman et al. 2005) . Apart from its association with PTB in the nucleus, raver1 interacts with the microfilament-associated protein vinculin, its muscle-specific splice variant metavinculin and alpha-actinin (Huttelmaier et al. 2001) . Indeed, raver1 was originally identified by its interaction with metavinculin in a yeast two-hybrid screen (Huttelmaier et al. 2001) ; during myotube formation in C2C12 cells, nuclear raver1 was shown to translocate to the cytoplasm and eventually to associate with myofibrils at the position of the Z-line. In differentiated skeletal muscle, raver1 colocalises with its cytoplasmic ligands (meta) vinculin and alpha-actinin at the region of sarcomeric Zlines and costameres (Huttelmaier et al. 2001) .
To gain further information about raver1 and its role in muscle differentiation, we embarked on a detailed analysis of the localisation of raver1 in mouse skeletal, heart and smooth muscle. To this end, we generated and characterised three monoclonal antibodies against different regions of the raver1 protein and employed them in immunofluorescence and immuno-electron microscopy. Our data revealed that raver1 was associated with cytoplasmic contractile elements in all three muscle types. Furthermore, raver1 was not restricted to costameres but was a prominent component of the I-Z-I region in striated muscle and the intercalated disc in heart. In addition, the nuclear localisation of raver1 was noted for all tissues examined.
Materials and methods

Raver1 antibodies
Three monoclonal antibodies of the IgG type were generated. Antibody 5G6 was raised against an N-terminal fragment of raver1 (Huttelmaier et al. 2001) . In the present study, the epitope of this antibody was mapped by pepscan analysis. Peptides (15-mers) of the raver1 sequence with an overlap of 12 amino acids between consecutive peptides were spot-synthesized on a cellulose membrane (Frank and Overwin 1996) and analysed for antibody binding as Fig. 1 Characterisation of monoclonal antibodies against various raver1 epitopes. a Representations of full-length raver1 and two complementary deletion constructs used in this study. The first and last amino acids of each construct are given (black boxes RNA recognition motifs, grey boxes nuclear localisation signals, hatched boxes central leucine-rich region, arrows binding positions of the monoclonal antibodies 5G6, 5D5 and 7D3). b The epitope recognised by 5G6 comprises amino acids 25-30 of raver1 as revealed by pepscan analysis. c Left Reactivity of the raver1 antibodies with recombinant raver1 and its deletion fragments as shown by SDSpolyacrylamide gel electrophoresis (SDS-PAGE) in immunoblots. Middle Antibody 5G6 recognises full-length raver1, a bouquet of its degradation products and raver1ΔC. Right Antibody 7D3 (and antibody 5D5; not shown) react with full length raver1 and raver1ΔN. d Reactivity of the raver1 antibodies with cell extracts. Equal amounts of proteins from murine C2C12 and human HeLa were subjected to SDS-PAGE, blotted and incubated with 5G6 (left), 5D5 (right) and 7D3 (not shown). Whereas the C-terminal antibodies recognised raver1 protein in samples of both cell types, 5G6 detected only murine raver1. e Part of the amino acid sequence of raver1 comprising the epitopes for 5G6 (left) and 7D3/5D5 (right) from various species. Note that the C-terminal sequence is highly conserved among vertebrate raver1 proteins, whereas the 5G6 epitope is only conserved in mouse and rat b described (Mayboroda et al. 1997) . Two additional antibodies (5D5 and 7D3) were raised against a C-terminal peptide (EPSPEGSY, corresponding to amino acids 718-727) of the protein, following standard protocols. The antibodies obtained were tested in solid phase binding assays, viz. enzyme-linked immunosorbent assays (ELISA), on recombinant protein and in immunoblots with total extracts of HeLa and C2C12 cells subjected to SDSpolyacrylamide gel electrophoresis (SDS-PAGE). Horseradish-peroxidase-coupled goat anti-mouse antibodies (Sigma) were used as secondary antibodies in both assays.
The raver1 antibodies were purified from hybridoma culture supernatants by affinity chromatography on antimouse IgG agarose (Sigma) columns. The binding and elution of antibodies were performed according to the supplier's protocol. Fractions (500 μl) were collected and immediately neutralised to pH 7.0 with 1 M TRIS pH 9.5. Aliquots were analysed by SDS-PAGE. Fractions containing high antibody concentrations were pooled and dialyzed against phosphate-buffered saline (PBS) overnight. The concentration of purified antibody was calculated from the absorption at an optical density of 280 nm by using an extinction coefficient of 1.35.
Cryosectioning and immunofluorescence labelling
Freshly isolated murine tissues (extensor digitorum longus, heart, uterus, urinary bladder) were mounted on egg white and cork (Jockusch and Voigt 2003) with Polyfreeze tissuefreezing medium (Polysciences). To prevent contraction, muscles were immoblilised with minutien pins. Specimens were frozen in melting isopentane prechilled in liquid nitrogen and stored at −80°C. They were sectioned (5-10 μm) in a cryostat at −20°C, mounted on glass slides and dried for at least 30 min. After being washed with PBS, the sections were briefly (10-20 s) incubated with 1% Triton X-100 and then fixed with 4% formaldehyde for 20 min, washed several times and permeabilised with 0.2% Triton X-100 at room temperature (RT) for 30 min. For indirect immunofluorescence, unspecific background labelling was first quenched by incubation with 5% bovine serum albumin (BSA) and 0.25 mg/ml Fab fragments (goat antimouse IgG; Dianova) in PBS at RT for 1 h. The sections were then washed in PBS, incubated with the monoclonal raver1 antibodies (cell culture supernatants) at RT for 1 h, washed three times in PBS and then incubated with goat anti-mouse Cy3 (diluted 1:200; Jackson Immuno Research). Samples were counterstained for F-actin and DNA with fluorescein-isothiocyanate-conjugated phalloidin (Sigma) and 4,6-diamidino-2-phenylindole (DAPI), respectively. Finally, samples were extensively washed in PBS, mounted in Mowiol, and examined with a Zeiss Axiophot microscope equipped with epifluorescence optics.
Preparation and staining of myofibrils Skeletal muscles were dissected from adult mice, incubated in Ringer's solution (100 mM NaCl, 2 mM MgCl 2 , 5 mM EGTA, 10 mM NaH 2 PO 4 , 0.1% glucose, 20 μM leupeptin, pH 7.4) on ice for 30 min and transferred to rigor buffer (100 mM KCl, 2 mM MgCl 2 , 2 mM EGTA, 0.3 mM dithiothreitole, 20 μM leupeptin, pH 7) at 5 ml per 0.5 g tissue. After homogenisation in a dounce homogeniser, samples were incubated for 10 min on ice under constant agitation, centrifuged at 1,500g for 30 min and resuspended in 10 volumes of ice-cold rigor buffer. These steps were repeated three times. Isolated myofibrils were stored in rigor buffer containing 50% glycerol at −20°C until use. For immunofluorescence, the myofibrils were allowed to adhere to glass slides for 1 min, rinsed with PBS and fixed with 4% formaldehyde for 10 min. After being washed, the samples were blocked with 5% BSA in PBS at RT for 2 h to reduce background labelling and stained for immunofluorescence as described above. Sarcomeric alpha-actinin was stained by using a monoclonal antibody (Sigma).
Immunoelectron microscopy For immunogold labelling, ultrathin sections were mounted on 200-mesh carbon/parlodion-coated copper grids. After the blocking of unspecific binding sites by two 5-min incubations in 2% BSA in PBS, grids were incubated on droplets of raver1 antibody solutions in a moist chamber at RT for 2 h. Optimal antibody concentrations were determined by titration experiments. For direct labelling, purified raver1 antibodies were conjugated to colloidal gold (Slot and Geuze 1985) . For indirect labelling, grids were rinsed with PBS after primary antibody incubation, blocked with 2% BSA in PBS (2×5 min) and then incubated with a secondary 10-nm gold-conjugated goat anti-mouse IgG (BBInternational) for 1 h at RT. After being washed in PBS and distilled H 2 O, grids were stained with 6% uranyl acetate for 1 h, rinsed with distilled H 2 O and then counterstained with lead-citrate for 2 min. For control experiments, the primary antibody was omitted (data not shown). Stained specimens were examined in a Hitatchi H7000 transmission electron microscope operated at 100 kV at 20,000× magnification. Micrographs were recorded on Kodak electron image film SO-163.
Gel electrophoresis and immunoblotting
Total protein extracts from C2C12 and HeLa cells were obtained as described by Huttelmaier et al. (2001) . Equal amounts of total protein were loaded onto 10% polyacrylamide gels. Following electrophoresis, samples were transferred onto nitrocellulose membranes and analysed for raver1 proteins following standard procedures as described by Huttelmaier et al. (2001) .
Recombinant protein expression and purification
Recombinant raver1 proteins were expressed by using the Bac-to-Bac-system according to the protocol of the manufacturer (Invitrogen). Briefly, cDNAs encoding full-length raver1, raver1ΔC (amino acids 1-441) and raver1ΔN (amino acids 442-748) were cloned into a modified pFastBac donor plasmid harbouring an additional FLAG tag sequence downstream of the histidine (His) tag and transformed into Escherichia coli DH10Bac cells. Recombinant bacmid DNA was isolated and transfected into sf9 (Spodoptera frugiperda) cells. The virus-containing supernatant was harvested and used for the infection of High Five insect cells. Cells were collected by centrifugation at 500 g for 5 min, washed with PBS containing leupeptin (20 μM) and stored at −70°C. His-tagged proteins were purified from insect cells according to the instructions of the manufacturer (Qiagen) with slight modifications as described by Witt et al. (2004) . Fractions containing the protein of interest were dialyzed against storage buffer, containing 50 mM sodium phosphate buffer pH 7.2, 0.2 mM EGTA, 4 μM pepstatin A, 40 μM leupeptin, Trasylol (2.8 mg/ml in H 2 O) and 14.3 mM β-mercaptoethanol, and stored on ice until use.
Results
Characterisation of raver1 antibodies
Three monoclonal antibodies, directed against different regions in the raver1 sequence (Fig. 1a) were employed to analyse the subcellular distribution of raver1 protein in muscle. The 5G6 antibody was raised against a recombinant MBP-tagged N-terminal raver1 fragment (amino acids 1-625) for the initial characterisation of raver1 (Huttelmaier et al. 2001) . We mapped the epitope of this antibody by pepscan analysis (Frank and Overwin 1996) and found that it recognised a series of four 15mer peptides (Fig. 1b) . From the minimal sequence overlap, we deduced the epitope ETVDRR corresponding to amino acids 25-30 of raver1. Antibodies 5D5 and 7D3 were raised against a C-terminal synthetic peptide (EPSPEGSY, comprising amino acids 718-727) and specifically recognised this peptide in ELISA and immunoblot assays (data not shown).
All three antibodies were tested for their reactivity with recombinant raver1 proteins in immunoblot assays (Fig. 1c and data not shown). Full length raver1 and the two complementary deletion constructs, raver1ΔC (amino acids 1-441) and raver1ΔN (amino acids 442-748), were purified from insect cells and subjected to SDS-PAGE (Fig. 1c, left) , which revealed major protein bands of 80 kDa for full-length raver1, approximately 51 kDa for raver1ΔC and approximately 35 kDa kDa for raver1ΔN. Degradation was only noted for the full-length protein. In immunoblots, antibody 5G6 recognised full-length raver1 and its proteolytic fragments and the N-terminal fragment raver1ΔC (Fig. 1c, middle) . In contrast, antibodies 5D5 and 7D3 bound to the C-terminal construct raver1ΔN in addition to the full length protein but failed to detect any degradation products (Fig. 1c, right and data not shown) . This indicated that the full-length protein was degraded from its C-terminus.
When tested on cell extracts (Fig. 1d) , all three antibodies recognised a protein band of approximately 80 kDa in murine C2C12 cells. In (human) HeLa cells, however, endogenous raver1 protein was only detected by the Cterminal antibodies (Fig. 1d , right and data not shown). Consistent with this finding, a comparison of known raver1 sequences revealed that the 5G6 epitope was not highly conserved among vertebrate species, whereas the epitope recognised by 5D5 and 7D3 was present in man, mouse, rat and Xenopus raver1 (Fig. 1e) .
Identification of raver1 as a myofibril component
In striated muscle, the raver1 ligand vinculin is restricted to attachment sites of the contractile apparatus in the sarcolemma, such as costameres and intercalated disks (Tokuyasu et al. 1981; Koteliansky and Gneushev 1983; Pardo et al. 1983; Witt et al. 2004 ), whereas alpha-actinin, another raver1-binding partner, is additionally present in the Z-disc (Tokuyasu et al. 1981; McKenna et al. 1986 ).
We therefore wanted to determine whether raver1 was confined to the costamere or constituted an integral part of sarcomeric structures. Frozen longitudinal sections of skeletal muscle from adult mice (extensor digitorum longus) yielded an identical staining pattern with all three raver1 antibodies (Fig. 2 and data not shown) . Raver1 was present as a doublet in the I-Z-I region, which was identified in the corresponding phase-contrast image. Notably, these doublets could only be seen in well-relaxed or stretched muscle. In contracted muscle, raver1 appeared as a single band colocalising with the Z-line (and may account for the staining observed in our previous investigation ; Huttelmaier et al. 2001) . To ascertain further the localisation of raver1 in muscle, myofibrils were isolated from murine skeletal muscle and labelled with raver1 antibodies yielding an identical staining pattern (Fig. 3a and data not shown). Again, raver1 was present as a doublet flanking the Z-disc on both sides, as was evident from a comparison with the corresponding phase-contrast images (Fig. 3a, left) and the staining of myofibrils for alpha-actinin (Fig. 3b) or actin (data not shown).
The sarcomeric localisation of raver1 was further examined by immunoelectron microscopy (Fig. 3c,d ). Gold particles were mainly distributed along the Z-disc in the I-Z-I region but were occasionally also found at the M-band (Fig. 3d) . Additionally, sections including the nucleus revealed raver1 as an intranuclear component (Fig. 3c) .
Localisation of raver1 in cardiac muscle
To study the distribution of raver1 in cardiac muscle, immunolabelling experiments were performed on murine ventricular heart tissue (Fig. 4) . Frozen sections were stained with 5G6 ( Fig. 4a) and 7D3 (Fig. 4b) . In longitudinal sections, a distinct sarcomeric banding pattern was observed that colocalised with the Z-discs of cardiomyocytes (Fig. 4a) . Distinct doublets were not as well resolved as in skeletal muscle (compare inset in Fig. 4a with Fig. 2 ). In addition, a strong raver1 signal was present at the intercalated discs connecting cardiomyocytes (arrowheads in Fig. 4a ). Raver1 staining in cardiomyocyte nuclei was weak (asterisks in Fig. 4b ) and often obscured by the sarcomeric signals. A similar reduction of nuclear signal intensity was described during the differentiation process of skeletal muscle (Huttelmaier et al. 2001) . Ultrastructural analyses by immunoelectron microscopy with 7D3 confirmed the dual residency of raver1 (Fig. 4c,d) . Immunogold labelling was prominent at the I-Z-I region (Fig. 4c ) and in the nucleus (Fig. 4d) . These data revealed that the localisation of raver1 at the sarcomeric boundary and in the nucleus was a common feature of striated muscle.
Analysis of raver1 distribution in smooth muscle
We also investigated the subcellular distribution of raver1 in smooth muscle in which the contractile apparatus is not organised in sarcomeres. Sections of murine urinary bladder (Fig. 5a ) and uterus (Fig. 5b) were analysed with 7D3 or 5D5, respectively. The smooth muscle cells of the urinary bladder (Fig. 5a , top left) were readily distinguished from adjacent connective tissue by strong cytoplasmic staining for raver1 (Fig. 5a, top right) and by the bright staining of filamentous actin by fluorescently labelled phalloidin (Fig. 5a , bottom left). A comparison of these images with DAPI staining (Fig. 5a , bottom right) clearly showed that raver1 was also present in smooth muscle nuclei (Fig. 5a, arrows) . Increased raver1 staining was also noted for the smooth muscle layer of blood vessels (Fig. 5a, boxed areas) . Sections of uterine smooth muscle (Fig. 5b, top left) confirmed the presence of raver1 in myofibrils (Fig. 5b, top right) , which were identified by phalloidin staining (Fig. 5b, bottom left) and the characteristic elongated shape of their nuclei (Fig. 5b,  bottom right) . The presence of raver1 in smooth muscle myofibrils was evident (see Fig. 5b ) but the resolution of the immunofluorescence images was not good enough to claim unambiguously its presence in smooth muscle nuclei.
At the ultrastructural level, the distribution of raver1 was examined in ultrathin sections of urinary bladder labelled with 5D5 (Fig. 6 ). Indirect immunogold labelling revealed Fig. 2 Localisation of raver1 in skeletal muscle of the mouse (extensor digitorum longus). Immunofluorescence analysis of frozen sections stained for raver1 with 5G6 (a), 5D5 (b) and 7D3 (not shown) revealed a striated pattern for each antibody. Higher magnifications (insets) of well-stretched muscle tissue (boxed regions) suggested that raver1 was localised as a doublet embracing the Z-lines. Bars 10 μm that raver1 was present in both nucleus and cytoplasm. In some instances, an association of raver1 with cytoplasmic filamentous structures possibly representing microfilaments was observed.
Discussion
We have previously observed that, during skeletal muscle differentiation, the hnRNP-like protein raver1 translocates from the nucleus to microfilament attachment sites in differentiated skeletal muscle at the sarcolemma (Huttelmaier et al. 2001) . Based on these findings, we have analysed the subcellular distribution of raver1 in skeletal muscle in more detail and expanded our investigation to heart and smooth muscle. We demonstrate that the cytoplasmic accumulation of raver1 and its association with contractile elements is a common feature of all three types of muscle. In addition, a minor fraction of the protein is always present in the nucleus. A detailed analysis of stretched myofibrils and ultrathin sections of skeletal muscle has shown that raver1, like alpha-actinin but unlike vinculin, is not restricted to the costameres. Instead, it is also an integral sarcomeric component, being mainly localised in the I-Z-I region. In heart muscle, raver1 is also found as a prominent component of intercalated discs, which are also rich in vinculin, metavinculin and alpha-actinin (Tokuyasu et al. 1981; Witt et al. 2004 ).
Immunolabelling of myofibrils (Fig. 3) has revealed that the distribution of raver1 does not exactly correspond to that of its ligand alpha-actinin. As expected, the latter is strictly confined to the Z-disc (Tokuyasu et al. 1981; McKenna et al. 1986 ), whereas raver1 flanks this structure, being thus mainly located in the I-regions. This partial overlap in situ either reflects a true differential localisation of the two proteins or is the consequence of steric hindrance of antibody binding caused by additional proteins. In vitro, raver1 directly interacts with vinculin and alpha-actinin and complexes containing all three proteins can be recovered from cell extracts by immunoprecipitation (Huttelmaier et al. 2001) . Based on our immunolabelling analyses, a direct interaction between raver1 and alpha-actinin in situ might be possible but cannot be proven.
As revealed by immunoelectron microscopy, raver1 is also occasionally found at the M-band (Figs. 3, 4) . Diverse locations within the sarcomere have also been described for other proteins such as obscurin (Young et al. 2001 ) and FHL2/DRAL (Lange et al. 2002) but, at present, whether translocations of such proteins occur within the sarcomere or whether distinct subpopulations of these components are present at different sites (Lange et al. 2006 ) is not clear.
The dual localisation of raver1 in the nuclear and sarcomeric compartment of muscle, together with its structural organisation indicating that is a member of a protein family engaged in RNA modification, suggests that raver1 may also have a dual function. Since raver1 harbours three RRMs and affects PTB-mediated RNA splicing in vitro (Gromak et al. 2003) , have speculated that raver1 might be involved in the processing and delivery Fig. 4 Subcellular localisation of raver1 in cardiomyocytes. Frozen longitudinal sections of mouse heart muscle were analysed for raver1 by 5G6 (a) and 7D3 (b) and counterstained with either fluoresceinisothiocyanate-conjugated phalloidin (a) or 4,6-diamidino-2-phenylindole (DAPI; b) to visualise the filamentous actin cytoskeleton or nuclei, respectively. a Left Corresponding phase-contrast image. Middle Raver1 is present in a striated pattern in cardiac sarcomeres (inset higher magnification of the boxed area, arrowhead intercalated disc). b A comparably weak raver1 signal, which is mainly obscured by sarcomeric striations, is detected in the centrally located nuclei (asterisks, placed immediately right of nuclei), which were counterstained by DAPI (right), in cardiac cells. Bars 10 μm. c, d Ultrathin sections of neonatal rat heart muscle, indirectly labelled with 7D3 and 10-nm gold (enlarged and pseudocoloured red). The sarcomeric (c, d) and nuclear (d) localisation of raver1 seen at the light-microscopic level is confirmed (C sarcoplasm, M M-band, N nucleus, Z Z-line). Bars 200 nm of specific mRNAs to the sarcomere and thus might mediate the site-specific synthesis of sarcomeric proteins. Such sarcomeric localisation has been reported for the mRNAs of vimentin, desmin and vinculin (Morris and Fulton 1994) .
However, direct RNA binding of raver1 remains to be shown. Alternatively, the RRMs may act as binding modules mediating protein-protein interactions and might be involved in vinculin binding (Huttelmaier et al. 2001) . However, other possibilities need to be considered. The functional plasticity of muscle is commonly accepted to depend critically on intracellular communicators that translate mechanical signals into altered protein activities or gene expression profiles. For example, a signalling complex involving the kinase domain (TK) of the giant sarcomeric protein titin regulates the nuclear translocation of MURF-2. Nuclear MURF-2 interacts with the transactivation domain of serum response factor (SRF), which indirectly leads to suppression of SRF-dependent muscle gene expression (Lange et al. 2005) . MURF-2 thus represents a member of a constantly growing, heterogeneous group of proteins that may translocate from the sarcomere to the nucleus to perform a sensory or messenger function. Other examples of such proteins are myopodin (Weins et al. 2001; Sanchez-Carbayo et al. 2003) , myo- Fig. 6 Immunoelectron microscopic analysis of raver1 in smooth muscle tissue. Ultrathin sections of smooth muscle from mouse urinary bladder (a) and mouse aorta (b) were labelled with 5D5 and a 10-nm goldconjugated secondary antibody (enlarged, pseudocoloured red). Raver1 is seen present in the nucleus (N) and cytoplasm (C) of both types of smooth muscle cells. Bars 200 nm palladin (Bang et al. 2001) and CARP, which is a nuclear modulator of gene expression in cardiac progenitor cells and cardiomyocytes (Jeyaseelan et al. 1997; Bang et al. 2001; Miller et al. 2003) . However, for most proteins the physiological consequences of these translocations remain to be shown (Lange et al. 2006) .
At present, we cannot determine whether raver1 exerts primarily structural, transport, signalling or regulatory functions in muscle. Raver1 knock-out mice are viable and fertile and myofibrils isolated from these animals are morphologically indistinguishable from their wild-type counterparts (B. Kleinhenz and H.H. Arnold, personal communication) . Even though we have recently identified a raver1-related protein (raver2; Kleinhenz et al. 2005) , the possibility of mere functional redundancy is unlikely, since raver2 is not expressed in muscle tissue. Furthermore, genetic analyses do not indicate any other raver isotypes. Thus, these findings argue against a purely structural function of raver1. The protein is apparently not required for initial sarcomere formation and maintenance. However, the possibility remains that, in costameres and intercalated disks, raver1 contributes to proper muscle function by modulating either the molecular architecture of microfilament attachment sites or the signalling pathways that target these attachment sites. Further studies, involving physiological analyses of raver1-depleted mice, their muscles and isolated myofibrils, are required to clarify these issues.
